HPV Linked to 40% Higher Cardiovascular Disease Risk, Study Shows

New meta-analysis of global studies highlights the potential role of HPV vaccination in reducing heart disease risk.

A meta-analysis presented at the American College of Cardiology's Annual Scientific Session confirms a significant association between HPV and cardiovascular disease.
HPV-positive patients have a 40% higher likelihood of developing cardiovascular disease and double the risk of coronary artery disease compared to HPV-negative individuals.
Even after adjusting for confounding factors, HPV-positive patients still exhibited a 33% increased risk of cardiovascular disease.
Researchers hypothesize chronic inflammation as the potential mechanism linking HPV to heart disease, though further investigation is needed.
Clinicians are encouraged to consider closer cardiovascular monitoring for HPV-positive patients, and researchers are exploring whether HPV vaccination could reduce heart disease risks.